Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
The temporal role of Histone Acetyl Transferases in cardiomyogenesis.
EF 2009-10
Résumé
Cardiovascular diseases are among the leading causes of death in North America. Currently, there are no effective treatment options for repairing the tissue damage resulting from heart attacks. Therefore, a therapeutic approach utilizing stem cells for the formation of heart msucle cells will be advantageous for replacing the damaged muscle following a heart attack. Stem cells are clinically important as they can give rise to all types of cells depending on the external and internal signals at the cellular level. Researchers have already identified the key molecules involved in the generation of heart muscle from stem cells. However, how these molecules interact with each other is unknown, and must be understood before it could be used for treatment. Therefore, the aim of this project is to understand the time dependant activity of these molecular triggers and key routes involved in the formation of heart muscle cells. In addition to this, the conditions necessary to maximize the heart muscle formation from stem cells will be studied using innovative biological technology. This project will open new avenues for research into treatment options that involve making stable and healthy heart muscle cells from a heart attack patient's own stem cells which can then be transplanted back into the patient. This will in turn effectively reverse the damage to the heart while overcoming the complications of tissue rejection, as the donor and the recepient of the cells will be the same person. If this approach can be translated into a clinical application, it will drastically reduce the deaths and disabilities that result from cardiovascular illnesses, thereby increasing the life expectancy and standard of living of these patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
201196
Name
Yilbas Ayse E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The temporal role of Histone Acetyl Transferases in cardiomyogenesis.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apotome Microscopy; Caridac Muscle; Chip; Histone Acetylation; Real Time Pcr; Stem Cell Differentiation; Transcription Regulation
Abstract
Cardiovascular diseases are among the leading causes of death in North America. Currently, there are no effective treatment options for repairing the tissue damage resulting from heart attacks. Therefore, a therapeutic approach utilizing stem cells for the formation of heart msucle cells will be advantageous for replacing the damaged muscle following a heart attack. Stem cells are clinically important as they can give rise to all types of cells depending on the external and internal signals at the cellular level. Researchers have already identified the key molecules involved in the generation of heart muscle from stem cells. However, how these molecules interact with each other is unknown, and must be understood before it could be used for treatment. Therefore, the aim of this project is to understand the time dependant activity of these molecular triggers and key routes involved in the formation of heart muscle cells. In addition to this, the conditions necessary to maximize the heart muscle formation from stem cells will be studied using innovative biological technology. This project will open new avenues for research into treatment options that involve making stable and healthy heart muscle cells from a heart attack patient's own stem cells which can then be transplanted back into the patient. This will in turn effectively reverse the damage to the heart while overcoming the complications of tissue rejection, as the donor and the recepient of the cells will be the same person. If this approach can be translated into a clinical application, it will drastically reduce the deaths and disabilities that result from cardiovascular illnesses, thereby increasing the life expectancy and standard of living of these patients.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yilbas, Ayse E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~